Literature DB >> 6123352

The effect of hydralazine on the pharmacokinetics of three different beta adrenoceptor antagonists: metoprolol, nadolol, and acebutolol.

D B Jack, M J Kendall, S Dean, S J Laugher, R Zaman, M E Tenneson.   

Abstract

The effect of hydralazine on the pharmacokinetics of metoprolol, nadolol, and acebutolol has been studied by measuring drug concentrations in plasma, serum, and urine. Metoprolol is affected by hydralazine, the AUC and Cmax being significantly increased. The kinetics of acebutolol and its major metabolite, diacetolol, are unaffected. Poor absorption of the polar beta blocker, nadolol, does not allow a firm conclusion to be drawn regarding the effect of hydralazine. It is concluded that only beta blockers with a substantial first-pass loss are likely to be significantly affected by hydralazine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6123352     DOI: 10.1002/bdd.2510030107

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  11 in total

1.  Separate and combined effects of nadolol and nifedipine on the cardiac response to exercise.

Authors:  M R Wilkins; K L Woods; D B Jack; M J Kendall; S J Laugher
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

2.  Drug interactions and beta blockers.

Authors:  L Beeley
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-17

3.  The effect of hydralazine on steady-state plasma concentrations of metoprolol in pregnant hypertensive women.

Authors:  S Lindeberg; B Holm; P Lundborg; C G Regårdh; B Sandström
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Lack of evidence for polymorphism in metoprolol metabolism.

Authors:  D B Jack; M Wilkins; C P Quarterman
Journal:  Br J Clin Pharmacol       Date:  1983-08       Impact factor: 4.335

5.  Dose-dependence of atenolol-ampicillin interaction.

Authors:  A J McLean; A Tonkin; P McCarthy; P Harrison
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

6.  Pharmacokinetic interactions between felodipine and metoprolol.

Authors:  S R Smith; M R Wilkins; D B Jack; M J Kendall; S Laugher
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

7.  Lack of a pharmacokinetic interaction between nifedipine and the beta-adrenoceptor blockers metoprolol and atenolol.

Authors:  M J Kendall; D B Jack; S J Laugher; J Lobo; S Rolf Smith
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

8.  Stable oral availability of sustained release propranolol when co-administered with hydralazine or food: evidence implicating substrate delivery rate as a determinant of presystemic drug interactions.

Authors:  A J Byrne; J J McNeil; P M Harrison; W Louis; A M Tonkin; A J McLean
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

9.  Effect of hydralazine on the elimination of antipyrine in the rat.

Authors:  C K Svensson; P W Knowlton; J A Ware
Journal:  Pharm Res       Date:  1987-12       Impact factor: 4.200

Review 10.  Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.

Authors:  P Benfield; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1986-05       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.